Holen Sie sich die Stockscreener-App
2.42
11.68%
-0.32
Handel nachbörslich:
2.50
0.08
+3.31%
Schlusskurs vom Vortag:
$2.74
Offen:
$2.73
24-Stunden-Volumen:
364.22K
Relative Volume:
1.19
Marktkapitalisierung:
$64.92M
Einnahmen:
$247.99M
Nettoeinkommen (Verlust:
$-521.97M
KGV:
-2.1802
EPS:
-1.11
Netto-Cashflow:
$-194.28M
1W Leistung:
-5.10%
1M Leistung:
-32.40%
6M Leistung:
-63.74%
1J Leistung:
-81.95%
1-Tages-Spanne:
$2.42
$2.8421
1-Wochen-Bereich:
$2.42
$2.96
52-Wochen-Spanne:
$2.42
$13.74
23 Andme Holding Co Stock (ME) Company Profile
Firmenname
23 Andme Holding Co
Sektor
Branche
Telefon
(650) 938-6300
Adresse
223 N. MATHILDA AVE., SUNNYVALE
Vergleichen Sie ME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
2.42 | 64.92M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-09-22 | Eingeleitet | Cowen | Outperform |
| 2021-11-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-12 | Eingeleitet | Citigroup | Buy |
23 Andme Holding Co Aktie (ME) Neueste Nachrichten
23andMe CEO Anne Wojcicki and New Mountain Capital offer to take company private - Marketscreener.com
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach - ACCESS Newswire
23andMe's Anne Wojcicki open (again) to third-party buyout of genetic testing companySan Francisco Business Times - The Business Journals
23andMe Holding Co. SEC 10-Q Report - TradingView
23andMe Launches New Genetic Report on Osteoporosis - GlobeNewswire
23andMe On The Brink? Exploring a Potential Sale Amid Financial Struggles! - Smartkarma
23andMe Sags on New Report - Baystreet.ca
23andMe Holding Co. (ME) Launches New Genetic Report on Osteoporosis - StreetInsider.com
23andMe Faces Financial Challenges Amid Revenue Growth - TipRanks
23Andme Holding Co earnings missed by $0.86, revenue topped estimates - Investing.com India
23andMe Board Explores Strategic Alternatives Amid Restructuring - GuruFocus.com
23andMe Reports Third Quarter Fiscal Year 2025 Financial Results - GlobeNewswire
23andMe Holding Begins Exploring Strategic Alternatives -January 29, 2025 at 03:49 am EST - Marketscreener.com
23andMe Holding Co. (ME) Reports Q3 Loss of $1.02 - StreetInsider.com
ME23andMe Holding Co. Latest Stock News & Market Updates - StockTitan
23andMe (NASDAQ:ME) Releases Quarterly Earnings Results - MarketBeat
23andMe says it's exploring alternatives, including a sale (ME:NASDAQ) - Seeking Alpha
23andMe Special Committee Announces Exploration of Strategic Alternatives - The Manila Times
23andMe Holding Co. (ME) to explore strategic alternatives, including possible sale - StreetInsider.com
23andMe Puts Itself Up for Sale: Major DNA Testing Company Could Change Hands - StockTitan
23andMe Holding Co. (ME) Halted, News Pending - StreetInsider.com
ME INVESTIGATION ALERT: 23andMe Holding Co. Shareholders are Alerted to Contact BFA Law regarding Ongoing Investigation into the Company (Nasdaq:ME) - ACCESS Newswire
ME INVESTOR UPDATE: BFA Law Alerts 23andMe Holding Co. Shareholders to Contact the Firm about its Investigation into the Company’s Board of Directors (Nasdaq:ME) - ACCESS Newswire
Deal Dispatch: Lovely Day To Sell Guinness? Plus, 23andMe To Rid Lineage Of Lemonaid - Benzinga
Predictive Genetic Testing and Consumer Genomics Market Research 2024-2034: Expanding DTC Genetic Testing, Consumer Interest in Personalized Healthcare, Awareness of Early Detection and Prevention - GlobeNewswire Inc.
23andMe Has Been Reportedly Quietly Explores a Possible Sale of its Telehealth Business, Lemonaid - Marketscreener.com
23andMe launches Discover23 to help accelerate genetics research - European Pharmaceutical Manufacturer
NewView Capital Partners I LLC Has $3.16 Million Holdings in 23andMe Holding Co. (NASDAQ:ME) - MarketBeat
Jane Street Group LLC Sells 1,561,678 Shares of 23andMe Holding Co. (NASDAQ:ME) - MarketBeat
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit's Trusted Technology - The Manila Times
23andMe Launches Discover23 to Help Accelerate Large-Scale - GlobeNewswire
23andMe Launches Discover23 Platform with Massive 4.7B Genetic Data Points for Medical Research - StockTitan
23andMe (NASDAQ:ME) Stock Price Down 0.3%Should You Sell? - MarketBeat
3 Promising US Penny Stocks With Over $9M Market Cap - Yahoo Finance
23andMe Stock Price Prediction: 2024, 2025, 2030 - Benzinga
23andMe Holding Co. (NASDAQ:ME) Short Interest Down 16.6% in November - MarketBeat
23Andme Holding Co earnings missed by $2.16, revenue topped estimates - Investing.com Nigeria
US Penny Stocks: 3 Picks With Market Caps Under $200M - Simply Wall St
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - MSN
23andMe (NASDAQ:ME) Trading 13.1% HigherHere's Why - MarketBeat
23andMe CEO Anne Wojcicki responds to critics, shares plan for company's future: "Essential for us to restructure" - CBS News
23andMe’s stock falls after company says there’s substantial doubt it can stay in business - MSN
23andMe shares dip as Q2 loss widens despite revenue beat By Investing.com - Investing.com Nigeria
Do Redditors Think That 23andMe Holding Co. (ME) Has a Big Upside Potential? - Insider Monkey
Struggling 23andMe Is Exploring Splitting the DNA Company in Two - MSN
23andMe inks research deal with Mirador Therapeutics By Investing.com - Investing.com Canada
Finanzdaten der 23 Andme Holding Co-Aktie (ME)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
3.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):